Added Value of inReach Software on Performance Characteristics of Standard Bronchoscopy
Not Applicable
Completed
- Conditions
- Lung Disease
- Registration Number
- NCT00817167
- Lead Sponsor
- superDimension Ltd.
- Brief Summary
The study is aimed to evaluate and describe the added value of inReach planning software on performance characteristics of standard bronchoscopy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Candidates for non-emergency bronchoscopy
- Must provide signed informed consent
- Male or female above 18 years old
- Lung lesions up to 3 cm in size (in largest diameter), non-visible by standard bronchoscope
Exclusion Criteria
- CT done over a month before the bronchoscopy procedure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Bronchoscopy Diagnostic Yield, compared between two study groups and calculated as percentage of true diagnoses from total number of bronchoscopy procedures. Until the definitive diagnosis is obtained
- Secondary Outcome Measures
Name Time Method Bronchoscopy Safety Profile, compared between two groups and calculated as percentage of bronchoscopy-related adverse events. At discharge from bronchoscopy unit
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does inReach software enhance in bronchoscopy for lung disease diagnosis?
How does inReach technology compare to standard bronchoscopy in terms of diagnostic accuracy and procedural efficiency?
Are there specific biomarkers that correlate with improved outcomes using inReach-assisted bronchoscopy?
What adverse events were observed in NCT00817167 and how were they managed compared to conventional methods?
What are the implications of inReach software on the future of bronchoscopy in early-stage lung cancer detection?
Trial Locations
- Locations (1)
Pulmonology Department, Tel Aviv Sourasky Medical Center
🇮🇱Tel Aviv, Israel
Pulmonology Department, Tel Aviv Sourasky Medical Center🇮🇱Tel Aviv, Israel